Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Rotrosen, MD
NYU Langone Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tarzana Treatment Centers
Tarzana, California, United States
- Gateway Community Services, Inc.
Jacksonville, Florida, United States
- Avery Road Treatment Center
Rockville, Maryland, United States
- Stanley Street Treatment and Resources
Fall River, Massachusetts, United States
- Turquoise Lodge Hospital
Albuquerque, New Mexico, United States
- Bellevue Hospital Center
New York, New York, United States
- Maryhaven
Columbus, Ohio, United States
- Evergreen Treatment Services
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jan 2014
- Primary completion
- 25 Jan 2017
- Completion
- 31 Jan 2017
- Last update posted
- 13 Aug 2020
- Registered enrollment
- 570
- Registry id
- NCT02032433
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.